PlainRecalls
FDA Drug Moderate Class II Terminated

Clozapine Tablets USP tablet, 100mg, 500-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-846-05

Reported: July 1, 2020 Initiated: June 12, 2020 #D-1370-2020

Product Description

Clozapine Tablets USP tablet, 100mg, 500-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-846-05

Reason for Recall

Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.

Details

Recalling Firm
Aurobindo Pharma USA Inc.
Units Affected
1440 bottles
Distribution
U.S.A. Nationwide
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Clozapine Tablets USP tablet, 100mg, 500-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-846-05. Recalled by Aurobindo Pharma USA Inc.. Units affected: 1440 bottles.
Why was this product recalled?
Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 1, 2020. Severity: Moderate. Recall number: D-1370-2020.